Evidence map›Paper›PMID 31173185›Full record

ArticleInternational journal of oncology2019

Cystathionine‑γ‑lyase promotes the metastasis of breast cancer via the VEGF signaling pathway.

Lupeng Wang, Haimei Shi, Ya Liu, Weiyuan Zhang, Xiaofang Duan, Ming Li, Xiaoyan Shi, Tianxiao Wang

Open access · hybridAbstract read
In one paragraph

Article in International journal of oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Emerging roles of hydrogen sulfide-metabolizing enzymes in cancer.Redox report : communications in free radical research · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Hydrogen sulfide and its role in female reproduction.Frontiers in veterinary science · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lupeng WangSchool of Pharmacy, Henan University, Kaifeng, Henan 475004, P.R. China.
Haimei ShiAnesthesiology Department, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.
Ya LiuSchool of Pharmacy, Henan University, Kaifeng, Henan 475004, P.R. China.
Weiyuan ZhangSchool of Pharmacy, Henan University, Kaifeng, Henan 475004, P.R. China.
Xiaofang DuanSchool of Pharmacy, Henan University, Kaifeng, Henan 475004, P.R. China.
Ming LiSchool of Pharmacy, Henan University, Kaifeng, Henan 475004, P.R. China.
Xiaoyan ShiSchool of Pharmacy, Henan University, Kaifeng, Henan 475004, P.R. China.
Tianxiao WangSchool of Pharmacy, Henan University, Kaifeng, Henan 475004, P.R. China.
Henan University · CNFirst Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to provide data to support the association between cystathionine‑γ‑lyase (CSE) and breast cancer metastasis. Reverse transcription‑quantitative polymerase chain reaction, immunohistochemistry and western blot analysis were used to detect the mRNA and protein expression levels of CSE in human breast cancer tissues and cells. MTS and 5‑ethynyl‑2'‑deoxyuridine assays were used to assess cell viability and proliferation. Scratch wound and Transwell assays were conducted to determine cell migration and invasion. In addition, hydrogen sulfide determination was performed using the methylene blue method. The expression of CSE was upregulated in samples from patients with breast cancer that also exhibit lymph node metastasis, and in grade III and readily metastatic breast cancer cell lines. The proliferation, migration and invasion of breast cancer cells were examined in the present study, and tumor metastasis was observed in nude mice. The function of CSE in breast cancer metastasis depends on the vascular endothelial growth factor (VEGF) signaling pathway, a key mediator of angiogenesis that is crucial for the development and metastasis of tumors. CSE positively regulated the expression of VEGF and increased the levels of certain key proteins in the VEGF pathway, including the phosphoinositide (PI3K)/protein kinase B (AKT) pathway [PI3K, Akt and phosphorylated (p)Akt], focal adhesion kinase (FAK)‑paxillin pathway (FAK and paxillin) and rat sarcoma (Ras)‑mitogen‑activated protein kinase pathway [Ras, rapidly accelerated fibrosarcoma, extracellular signal‑regulated kinase (ERK)1/2 and pERK1/2]. Furthermore, the novel CSE inhibitor I157172 possessed antiproliferative and anti‑metastatic activities in early MDA‑MB‑231 metastatic breast cancer cells via inhibition of the VEGF signaling pathway, which further confirmed the role of CSE in breast cancer metastasis. Overall, these data demonstrate for the first time, to the best of our knowledge, that the functions of CSE in breast cancer metastasis are associated with the VEGF signaling pathway.

Indexed as

Cell MovementAdultAgedAnimalsApoptosisBiomarkers, TumorBreast NeoplasmsCell ProliferationCystathionine gamma-LyaseFemaleFollow-Up StudiesGene Expression Regulation, NeoplasticHumansLung NeoplasmsLymphatic MetastasisMiceBiomarkers, TumorCystathionine gamma-LyaseVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID31173185
PMCPMC6615928
OpenAlexW2948181462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.